Lindsay Rosenwald on Improving Cancer Survival Rates

Lindsay RosenwaldAccording to Investment Partnership co-founder Lindsay Rosenwald, medical experts continue to make strides toward eradicating cancer. Lindsay Rosenwald believes that the increase in cancer diagnoses has resulted in more research and development projects related to the disease. Recently, Lindsay Rosenwald discussed how technological advancements have assisted in the improvement of cancer survival rates.

A Gathering of Experts: Is the population of cancer patients increasing?

Lindsay Rosenwald: More people are being diagnosed with cancer due in part to an aging, growing population and better diagnostic technology.

A Gathering of Experts: How is the medical community coping with this epidemic?

Lindsay Rosenwald: The survival rates are improving because of new therapies that have been primarily developed by American biotechnology companies.

A Gathering of Experts: What has been the key factor in the treatment of cancer patients?

Lindsay Rosenwald: Medical experts continue their efforts to increase access to the latest cancer control methods and raise awareness about them.

A Gathering of Experts: How can patients curb the symptoms of cancer?

Lindsay Rosenwald: Effective therapies are available that control cancer and cancer treatment; side effects including nausea, mouth sores and general pain.

A Gathering of Experts: How has technology played a role in cancer research?

Lindsay Rosenwald: The industry continues its efforts to optimize its usage of information technology in order to facilitate cancer research while accelerating all other efforts designed to control cancer.

A Gathering of Experts: How is the medical community reacting to the current state of cancer?

Lindsay Rosenwald: As time goes on, the medical community continues to invest in cancer research in an effort to improve global health.

A Gathering of Experts: How so?

Lindsay Rosenwald: Combination chemotherapy is now standard in treating many cancers and has contributed to increasing survival and cure rates.

A Gathering of Experts: What’s one major example?
Lindsay Rosenwald: Combination chemotherapy involving the drug Cisplatin led to cure rates for testicular cancer of nearly 95 percent.

A Gathering of Experts: How effective has treatment been?

Lindsay Rosenwald: Treatment has been so effective that approximately 80 percent of patients with metastatic testicular cancer can now be cured.

A Gathering of Experts: What’s the status of cancer vaccines?

Lindsay Rosenwald: Multiple cancer and cancer prevention vaccines have been approved so far by the FDA, and many more are in the development pipeline.

A Gathering of Experts: Could you describe them?

Lindsay Rosenwald: One of the cancer prevention vaccines, the hepatitis B virus vaccine, could potentially prevent several forms of liver cancer.

A Gathering of Experts: That’s remarkable.

Lindsay Rosenwald: It’s very encouraging. Two vaccines target human papillomavirus (HPV) types 16 and 18.

A Gathering of Experts: How will these vaccines help eradicate cancer?

Lindsay Rosenwald: These vaccines have an enormous potential to prevent an estimated 70 percent of all cervical cancers, as well as other HPV-associated cancers.

A Gathering of Experts: What other diseases might potentially be treated?

Lindsay Rosenwald: Several cancer treatment vaccines are being tested in clinical trials, including vaccines for ovarian cancer, pancreatic cancer, multiple myeloma and melanoma.

A Gathering of Experts: Have medical professionals experimented with different types of therapy?

Lindsay Rosenwald: Medical experts have further refined their radiation therapy techniques as well.

A Gathering of Experts: What have these therapies achieved?

Lindsay Rosenwald: These recent advances have resulted in much better patient outcomes, including survival benefits.

Lindsay Rosenwald is an accomplished doctor and financial professional with more than three decades of experience in the medical field.